Polymorphisms of Multidrug Resistance Gene (MDR1) and Cyclosporine Absorption in De Novo Renal Transplant Patients
Authors:
- 27 May 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 83 (10) , 1380-1384
Abstract
Background. Several single nucleotide polymorphisms (SNPs) in the multidrug resistance (MDR1) gene may play a role in the interindividual variation of cyclosporine A (CsA) absorption in renal transplant patients. Methods. An analysis of CsA absorption measured by the dose- and weight-adjusted 4 hr area under the time-concentration curve, AUC(0–4)/mg doseCsA/kg, was conducted on day 3 after transplantation, in 69 de novo renal transplant patients who were genotyped for MDR1 SNPs. Follow-up pharmacogenomic analysis at 1 month posttransplant was performed utilizing dose- and weight-adjusted 2-hour postdose CsA concentration (C2). Results. AUC(0–4)/mg doseCsA/kg was significantly higher (P=0.024) in (C/C)3435 individuals than in a grouped population of (C/T)3435 and (T/T)3435 patients on postoperative day 3. G2677T variants were not significantly correlated with CsA absorption (P=0.084). The number of C3435-G2677 haplotypes was the best predictor of CsA exposure. At 1 month posttransplant, no correlation was seen between MDR1 SNPs and CsA exposure. The frequency of wild-type variants for C3435T and G2677T were 61% and 77.6%, respectively. SNPs at G2677T and C3435T loci were found to be in linkage disequilibrium. Conclusions. MDR1 polymorphisms are associated with differences in CsA exposure only in the first posttransplant week.Keywords
This publication has 28 references indexed in Scilit:
- MDR-1 C3435T Polymorphism Influences Cyclosporine A Dose Requirement in Liver-Transplant RecipientsTransplantation, 2004
- The Effect of CYP3A5 and MDR1 Polymorphic Expression on Cyclosporine Oral Disposition in Renal Transplant PatientsThe Journal of Clinical Pharmacology, 2003
- Modulation of steady‐state kinetics of digoxin by haplotypes of the P‐glycoprotein MDR1 geneClinical Pharmacology & Therapeutics, 2002
- The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humansAdvanced Drug Delivery Reviews, 2002
- Adequate Early Cyclosporin Exposure is Critical to Prevent Renal Allograft Rejection: Patients Monitored by Absorption ProfilingAmerican Journal of Transplantation, 2002
- The Structure of Haplotype Blocks in the Human GenomeScience, 2002
- Cyclosporine Microemulsion (Neoral®) Absorption Profiling and Sparse-sample Predictors During the First 3 Months after Renal TransplantationAmerican Journal of Transplantation, 2002
- Identification of functionally variant MDR1 alleles among European Americans and African AmericansClinical Pharmacology & Therapeutics, 2001
- Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivoProceedings of the National Academy of Sciences, 2000
- VARIABLE ORAL ABSORPTION OF CYCLOSPORINETransplantation, 1996